Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNIK | Q9UKE5 | 2/20 | 0.35 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 11/20 | 0.33 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6709988 | 0.93 | TNIK (0.35) | TNIKCSNK2A1HIF1AGPR35NPSR1 | |
| SCHEMBL6707764 | 0.91 | HIF1A (0.41) | CSNK2A1HIF1AMEN1KMT2ARXFP1 | |
| SCHEMBL6709217 | 0.89 | HIF1A (0.38) | HIF1AGPR35MEN1HPGDKMT2A | |
| SCHEMBL6708030 | 0.89 | ALDH1A1 (0.39) | HIF1AMEN1KMT2ANPSR1RXFP1 | |
| SCHEMBL6710349 | 0.88 | HIF1A (0.38) | HIF1AGPR35MEN1HPGDKMT2A | |
| SCHEMBL6710477 | 0.88 | TNIK (0.38) | TNIKCSNK2A1HIF1AMAPT | |
| SCHEMBL6707828 | 0.87 | SLC10A6 (0.36) | HIF1AGPR35MEN1KMT2AMAPT | |
| SCHEMBL6713076 | 0.86 | AURKA (0.35) | HIF1AGPR35MEN1HPGDKMT2A | |
| SCHEMBL6709874 | 0.85 | GRIK1 (0.39) | TNIKCSNK2A1HIF1AMEN1HPGD | |
| SCHEMBL6710273 | 0.85 | HIF1A (0.44) | HIF1AGPR35MEN1HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | TNIK 1147/4885CSNK2A1 4099/4885HIF1A 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.